ReviewNuclear medicine and molecular imaging2014
Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.
Review in Nuclear medicine and molecular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Prognostic Value of MTV and TLG ofContrast media & molecular imaging · 2021Pooled it
- Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis.European journal of nuclear medicine and molecular imaging · 2015Pooled it
- Prognostic Implications of Volume-based Quantitative 18F-FDG PET/CT Biomarkers in Pulmonary Sarcoidosis.Clinical nuclear medicine · 2026Article
- Predictive value ofBMC cancer · 2025Article
- A multi-view prognostic model for diffuse large B-cell lymphoma based on kernel canonical correlation analysis and support vector machine.BMC cancer · 2024Article
- The role of baselineTherapeutic advances in medical oncology · 2024Review
- Assessment of androgen receptor expression in breast cancer patients using 18 F-FDG PET/CT radiomics and clinicopathological characteristics.BMC medical imaging · 2023Article
- Article
- Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022Article
- Artificial Intelligence in Lymphoma PET Imaging:: A Scoping Review (Current Trends and Future Directions).PET clinics · 2022Article
- Article
- Advances in Quantitative Analysis ofMolecular imaging · 2021Review
- Predictive Value of Metabolic Parameters Derived FromFrontiers in immunology · 2021Article
- Article
- Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A Review.Biomedicines · 2020Review
- Whole-vessel coronaryEuropean journal of nuclear medicine and molecular imaging · 2020Article
- Relationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1α, prognosis andTranslational cancer research · 2020Article
- What can artificial intelligence teach us about the molecular mechanisms underlying disease?European journal of nuclear medicine and molecular imaging · 2019Review
- Correlations between the metabolic profile andScientific reports · 2019Article
- HybridCancers · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Image quantification studies in positron emission tomography/computed tomography (PET/CT) are of immense importance in the diagnosis and follow-up of variety of cancers. In this review we have described the current image quantification methodologies employed in (18)F-fluorodeoxyglucose ((18)F-FDG) PET in major oncological conditions with particular emphasis on tumor heterogeneity studies. We have described various quantitative parameters being used in PET image analysis. The main contemporary methodology is to measure tumor metabolic activity; however, analysis of other image-related parameters is also increasing. Primarily, we have identified the existing role of tumor heterogeneity studies in major cancers using (18)F-FDG PET. We have also described some newer radiopharmaceuticals other than (18)F-FDG being studied/used in the management of these cancers. Tumor heterogeneity studies are being performed in almost all major oncological conditions using (18)F-FDG PET. The role of these studies is very promising in the management of these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.